Kenna Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kenna Brown has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Chelsea M. Heveran
Department of Mechanical & Industrial Engineering, Montana State University, Bozeman, USA
4 shared publications - Stephen A. Martin
Biology of Aging Laboratory, Montana State University, Bozeman, MT USA
2 shared publications Ana C Ferreira Ruble
Department of Orthopedics, University of Colorado Anschutz Medical Campus , Aurora, CO 80045 , United States
1 shared publication- Beatriz Bermudez
Department of Mechanical Engineering, University of Colorado Denver , Denver, CO 80204 , United States
1 shared publication Brady D. Hislop
Department of Mechanical & Industrial Engineering, Montana State University, Bozeman, USA
1 shared publication- Cheryl L. Ackert-Bicknell
Colorado Program for Musculoskeletal Research, Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO
1 shared publication
Latest Publications
- Open Access
Bone microarchitecture and material properties decline differently across midlife for male and female F344 × BN F1 rats
While bone mineral density (BMD) remains the clinical standard for assessing age-related fracture risk, accumulating evidence indicates that bone quality, including matrix properties and microarchitecture, contributes to fracture susceptibility in ways not captured by BMD alone. As matrix-targeted therapeutics emerge, preclinical models that exhibit translationally relevant bone quality changes are needed. Here, we evaluated the Fischer 344 × Brown Norway (F344×BN) F1 rat, a strain characterized by hybrid vigor and non-pathological aging, as a model for studying matrix-related mechanisms of skeletal aging. Femurs from male and female rats aged 7, 15, and 22 months were analyzed to quantify age- and sex-dependent changes in bone microarchitecture, fracture resistance, and matrix properties. Microcomputed tomography analyses revealed sexually dimorphic aging trajectories. From 7 to 22 months, females exhibited moderate declines in trabecular microarchitecture and no change in cortical porosity, whereas males showed pronounced trabecular deterioration and increased cortical porosity. Whole-bone flexural testing demonstrated age-related declines in material properties that were not attributable to changes in geometry, while females maintained geometry-scaled bone strength. Both sexes exhibited reduced bone toughness with age. Raman spectroscopy identified matrix-level alterations in males by 15 months, whereas systemic markers of bone turnover remained unchanged across age or sex. Together, these findings indicate that males exhibit combined tissue-scale and whole-bone deterioration by midlife, while females exhibit declining fracture resistance preceding substantial cortical bone loss or overt matrix deterioration. These results support the F344×BN F1 rat as a translational model for investigating matrix-driven skeletal aging. Lay summary: F344 x BN F1 hybrid rats provide a healthy, matrix-driven skeletal aging model. This strain exhibits distinct aging trajectories dependent on sex. Strength and toughness decrease in both sexes by midlife. Fracture resistance declines in females prior to substantial bone loss.
Open AccessBone microarchitecture and material properties decline differently across midlife for male and female F344 × BN F1 rats
While bone mineral density (BMD) remains the clinical standard for assessing age-related fracture risk, accumulating evidence indicates that bone quality, including matrix properties and microarchitecture, contributes to fracture susceptibility in ways not captured by BMD alone. As matrix-targeted therapeutics emerge, preclinical models that exhibit translationally relevant bone quality changes are needed. Here, we evaluated the Fischer 344 × Brown Norway (F344×BN) F1 rat, a strain characterized by hybrid vigor and non-pathological aging, as a model for studying matrix-related mechanisms of skeletal aging. Femurs from male and female rats aged 7, 15, and 22 months were analyzed to quantify age- and sex-dependent changes in bone microarchitecture, fracture resistance, and matrix properties. Microcomputed tomography analyses revealed sexually dimorphic aging trajectories. From 7 to 22 months, females exhibited moderate declines in trabecular microarchitecture and no change in cortical porosity, whereas males showed pronounced trabecular deterioration and increased cortical porosity. Whole-bone flexural testing demonstrated age-related declines in material properties that were not attributable to changes in geometry, while females maintained geometry-scaled bone strength. Both sexes exhibited reduced bone toughness with age. Raman spectroscopy identified matrix-level alterations in males by 15 months, whereas systemic markers of bone turnover remained unchanged across age or sex. Together, these findings indicate that males exhibit combined tissue-scale and whole-bone deterioration by midlife, while females exhibit declining fracture resistance preceding substantial cortical bone loss or overt matrix deterioration. These results support the F344×BN F1 rat as a translational model for investigating matrix-driven skeletal aging. Lay summary: F344 x BN F1 hybrid rats provide a healthy, matrix-driven skeletal aging model. This strain exhibits distinct aging trajectories dependent on sex. Strength and toughness decrease in both sexes by midlife. Fracture resistance declines in females prior to substantial bone loss.
- Open Access
- 3 June 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-19
Short-term high-fat diet impacts bone material properties and metabolism for adult and aged C57BL/6JN mice
The elderly are at increased risk of bone fracture and more often consume poor quality diets, such as high-fat diet (HFD). We hypothesized that HFD exacerbates the loss of bone fracture resistance in aging. Female and male 5-month and 22-month C57BL/6JN mice were fed moderate HFD (45%) or low-fat diet (10%) for 8 weeks. All HFD groups showed disrupted glucose metabolism. Aging and HFD lowered bone fracture toughness, while aging alone reduced bone strength. Raman Spectroscopy demonstrated that aging and HFD differently impact bone matrix. Aging altered matrix properties but the effect depended on sex. Both sexes had higher carbonate content and altered collagen structure (I1670/I1690) with age but males also had increased crystallinity. HFD decreased mineral maturity (i.e., crystallinity) as well as altered collagen structure in females but not males. Untargeted metabolomics revealed that cortical tissue metabolism was dysregulated with aging and HFD. Aging and HFD affected pathways related to cellular function and viability, or glucose regulation, respectively. In aging mice, HFD also impacted osteoclast and adipocyte abundance and osteocyte viability in both sexes. Together, these data demonstrate that HFD exacerbates the loss of bone matrix quality and fracture resistance in aging C57BL/6JN mice.
- 3 June 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-19
Open AccessShort-term high-fat diet impacts bone material properties and metabolism for adult and aged C57BL/6JN mice
The elderly are at increased risk of bone fracture and more often consume poor quality diets, such as high-fat diet (HFD). We hypothesized that HFD exacerbates the loss of bone fracture resistance in aging. Female and male 5-month and 22-month C57BL/6JN mice were fed moderate HFD (45%) or low-fat diet (10%) for 8 weeks. All HFD groups showed disrupted glucose metabolism. Aging and HFD lowered bone fracture toughness, while aging alone reduced bone strength. Raman Spectroscopy demonstrated that aging and HFD differently impact bone matrix. Aging altered matrix properties but the effect depended on sex. Both sexes had higher carbonate content and altered collagen structure (I1670/I1690) with age but males also had increased crystallinity. HFD decreased mineral maturity (i.e., crystallinity) as well as altered collagen structure in females but not males. Untargeted metabolomics revealed that cortical tissue metabolism was dysregulated with aging and HFD. Aging and HFD affected pathways related to cellular function and viability, or glucose regulation, respectively. In aging mice, HFD also impacted osteoclast and adipocyte abundance and osteocyte viability in both sexes. Together, these data demonstrate that HFD exacerbates the loss of bone matrix quality and fracture resistance in aging C57BL/6JN mice.
- Open Access
- 10 January 2024
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (4) , ziad011
Sex-specific effects of Fat-1 transgene on bone material properties, size, and shape in mice
Western diets are becoming increasingly common around the world. Western diets have high omega 6 (ω-6) and omega 3 (ω-3) fatty acids and are linked to bone loss in humans and animals. Dietary fats are not created equal; therefore, it is vital to understand the effects of specific dietary fats on bone. We aimed to determine how altering the endogenous ratios of ω-6:ω-3 fatty acids impacts bone accrual, strength, and fracture toughness. To accomplish this, we used the Fat-1 transgenic mice, which carry a gene responsible for encoding a ω-3 fatty acid desaturase that converts ω-6 to ω-3 fatty acids. Male and female Fat-1 positive mice (Fat-1) and Fat-1 negative littermates (WT) were given either a high-fat diet (HFD) or low-fat diet (LFD) at 4 wk of age for 16 wk. The Fat-1 transgene reduced fracture toughness in males. Additionally, male BMD, measured from DXA, decreased over the diet duration for HFD mice. In males, neither HFD feeding nor the presence of the Fat-1 transgene impacted cortical geometry, trabecular architecture, or whole-bone flexural properties, as detected by main group effects. In females, Fat-1-LFD mice experienced increases in BMD compared to WT-LFD mice; however, cortical area, distal femur trabecular thickness, and cortical stiffness were reduced in Fat-1 mice compared to pooled WT controls. However, reductions in stiffness were caused by a decrease in bone size and were not driven by changes in material properties. Together, these results demonstrate that the endogenous ω-6:ω-3 fatty acid ratio influences bone material properties in a sex-dependent manner. In addition, Fat-1 mediated fatty acid conversion was not able to mitigate the adverse effects of HFD on bone strength and accrual. As Western diets increase in popularity, it is becoming imperative to understand the impact of fatty acids in these diets on bone health. Western diets, known to increase the risk of bone fractures, contain large amounts of omega-6 (ω-6) fatty acids. Although evidence suggests that ω-6 fatty acids may be detrimental to bone health, it is important to consider the interaction between both ω-6 and omega-3 (ω-3) fatty acids, as fats are not consumed in isolation. To control the ratio of ω-6:ω-3 fatty acids, we used a transgenic mouse model that converts ω-6 fatty acids to ω-3 fatty acids within every cell. However, male and female Fat-1 positive (Fat-1) and Fat-1 negative (WT) mice were given either a high-fat diet (HFD) or low-fat diet (LFD) for 4 mo. In males, bone strength remained unchanged, but resistance to fracture decreased when the ω-6:ω-3 fatty acid ratio was reduced. In females, bone strength was reduced, but resistance to fracture remained unchanged. The evidence provided reveals that sex significantly influences how dietary fat impacts bone strength and fracture resistance, thereby enhancing our understanding of the relationship between bone health and fat.
- 10 January 2024
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (4) , ziad011
Open AccessSex-specific effects of Fat-1 transgene on bone material properties, size, and shape in mice
Western diets are becoming increasingly common around the world. Western diets have high omega 6 (ω-6) and omega 3 (ω-3) fatty acids and are linked to bone loss in humans and animals. Dietary fats are not created equal; therefore, it is vital to understand the effects of specific dietary fats on bone. We aimed to determine how altering the endogenous ratios of ω-6:ω-3 fatty acids impacts bone accrual, strength, and fracture toughness. To accomplish this, we used the Fat-1 transgenic mice, which carry a gene responsible for encoding a ω-3 fatty acid desaturase that converts ω-6 to ω-3 fatty acids. Male and female Fat-1 positive mice (Fat-1) and Fat-1 negative littermates (WT) were given either a high-fat diet (HFD) or low-fat diet (LFD) at 4 wk of age for 16 wk. The Fat-1 transgene reduced fracture toughness in males. Additionally, male BMD, measured from DXA, decreased over the diet duration for HFD mice. In males, neither HFD feeding nor the presence of the Fat-1 transgene impacted cortical geometry, trabecular architecture, or whole-bone flexural properties, as detected by main group effects. In females, Fat-1-LFD mice experienced increases in BMD compared to WT-LFD mice; however, cortical area, distal femur trabecular thickness, and cortical stiffness were reduced in Fat-1 mice compared to pooled WT controls. However, reductions in stiffness were caused by a decrease in bone size and were not driven by changes in material properties. Together, these results demonstrate that the endogenous ω-6:ω-3 fatty acid ratio influences bone material properties in a sex-dependent manner. In addition, Fat-1 mediated fatty acid conversion was not able to mitigate the adverse effects of HFD on bone strength and accrual. As Western diets increase in popularity, it is becoming imperative to understand the impact of fatty acids in these diets on bone health. Western diets, known to increase the risk of bone fractures, contain large amounts of omega-6 (ω-6) fatty acids. Although evidence suggests that ω-6 fatty acids may be detrimental to bone health, it is important to consider the interaction between both ω-6 and omega-3 (ω-3) fatty acids, as fats are not consumed in isolation. To control the ratio of ω-6:ω-3 fatty acids, we used a transgenic mouse model that converts ω-6 fatty acids to ω-3 fatty acids within every cell. However, male and female Fat-1 positive (Fat-1) and Fat-1 negative (WT) mice were given either a high-fat diet (HFD) or low-fat diet (LFD) for 4 mo. In males, bone strength remained unchanged, but resistance to fracture decreased when the ω-6:ω-3 fatty acid ratio was reduced. In females, bone strength was reduced, but resistance to fracture remained unchanged. The evidence provided reveals that sex significantly influences how dietary fat impacts bone strength and fracture resistance, thereby enhancing our understanding of the relationship between bone health and fat.
- Open Access
- 10 January 2024
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (2) , ziae001
Rapamycin does not alter bone microarchitecture or material properties quality in young-adult and aged female C57BL/6 mice
Advancing age is the strongest risk factor for osteoporosis and skeletal fragility. Rapamycin is an FDA-approved immunosuppressant that inhibits the mechanistic target of rapamycin (mTOR) complex, extends lifespan, and protects against aging-related diseases in multiple species; however, the impact of rapamycin on skeletal tissue is incompletely understood. We evaluated the effects of a short-term, low-dosage, interval rapamycin treatment on bone microarchitecture and strength in young-adult (3 mo old) and aged female (20 mo old) C57BL/6 mice. Rapamycin (2 mg/kg body mass) was administered via intraperitoneal injection 1×/5 d for a duration of 8 wk; this treatment regimen has been shown to induce geroprotective effects while minimizing the side effects associated with higher rapamycin dosages and/or more frequent or prolonged delivery schedules. Aged femurs exhibited lower cancellous bone mineral density, volume, trabecular connectivity density and number, higher trabecular thickness and spacing, and lower cortical thickness compared to young-adult mice. Rapamycin had no impact on assessed microCT parameters. Flexural testing of the femur revealed that both yield strength and ultimate strength were lower in aged mice compared to young-adult mice. There were no effects of rapamycin on these or other measures of bone biomechanics. Age, but not rapamycin, altered local and global measures of bone turnover. These data demonstrate that short-term, low-dosage interval rapamycin treatment does not negatively or positively impact the skeleton of young-adult and aged mice.
- 10 January 2024
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (2) , ziae001
Open AccessRapamycin does not alter bone microarchitecture or material properties quality in young-adult and aged female C57BL/6 mice
Advancing age is the strongest risk factor for osteoporosis and skeletal fragility. Rapamycin is an FDA-approved immunosuppressant that inhibits the mechanistic target of rapamycin (mTOR) complex, extends lifespan, and protects against aging-related diseases in multiple species; however, the impact of rapamycin on skeletal tissue is incompletely understood. We evaluated the effects of a short-term, low-dosage, interval rapamycin treatment on bone microarchitecture and strength in young-adult (3 mo old) and aged female (20 mo old) C57BL/6 mice. Rapamycin (2 mg/kg body mass) was administered via intraperitoneal injection 1×/5 d for a duration of 8 wk; this treatment regimen has been shown to induce geroprotective effects while minimizing the side effects associated with higher rapamycin dosages and/or more frequent or prolonged delivery schedules. Aged femurs exhibited lower cancellous bone mineral density, volume, trabecular connectivity density and number, higher trabecular thickness and spacing, and lower cortical thickness compared to young-adult mice. Rapamycin had no impact on assessed microCT parameters. Flexural testing of the femur revealed that both yield strength and ultimate strength were lower in aged mice compared to young-adult mice. There were no effects of rapamycin on these or other measures of bone biomechanics. Age, but not rapamycin, altered local and global measures of bone turnover. These data demonstrate that short-term, low-dosage interval rapamycin treatment does not negatively or positively impact the skeleton of young-adult and aged mice.